Name Moshe Szyf | ||
 | ||
Books DNA Methylation and Cancer Therapy. Medical Intelligence Unit. Fields Epigenetics, Cancer research | ||
Rsa nspcc event how nurture alters nature moshe szyf
Moshe Szyf is a geneticist and James McGill professor of pharmacology and therapeutics at the McGill University, where he also holds a GlaxoSmithKline-CIHR chair in pharmacology.
Contents
- Rsa nspcc event how nurture alters nature moshe szyf
- Moshe szyf behavioral epigenetics
- Education and career
- Publications
- References
Szyf's main research interests lie with epigenetics, including behavioral epigenetics as well as cancer research.
Moshe szyf behavioral epigenetics
Education and career
Szyf received his Ph.D. from the Hebrew University on basic mechanisms of DNA methylation under supervision of Aharon Razin. Subsequently, he performed postdoctoral work at Harvard Medical School. In 1989, he was appointed as assistant professor in pharmacology and therapeutics at McGill University. In 2016, Moshe Szyf founded Montreal EpiTerapia Inc.
Publications
As of October 2013, Moshe Szyf published more than 140 papers in peer-reviewed journals, almost all on epigenetics. He is also on the Editorial Board of the journal Environmental Epigenetics, published by Oxford University Press.
Szyf also holds many patents, all relating to epigenetics-based therapeutics.